Is vulnerability to cardiometabolic disease in Indians mediated by abdominal adiposity or higher body adiposity

BMC Public Health

Table 5 Linear regressions showing adiposity in relation to cardiometabolic risk factors among APCAPS participants stratified by sex

	Men		Women
	Age and sex adjusted Coefficient (95% CI)	P, value	Age and sex adjusted Coefficient (95% CI)	P-value
Cholesterol	N = 959		N = 412
DXA Total fat (g)	0.24 (0.18, 0.30)	<0.001	0.11 (0.03, 0.19)	0.01
BMI kg/m²	0.23 (0.17, 0.29)	<0.001	0.10 (0.03, 0.18)	0.005
Bodyfat (skinfolds)	0.23 (0.17, 0.29)	<0.001	0.10 (0.03, 0.18)	0.01
DXA L1L4 fat (g)	0.25 (0.19, 0.31)	<0.001	0.10 (0.02, 0.18)	0.02
WHR	0.16 (0.10, 0.21)	<0.001	0.07 (-0.01, 0.16)	0.08
Waist circumference	0.23 (0.17, 0.29)	<0.001	0.13 (0.05, 0.20)	0.003
SBP	N = 959		N = 412
DXA Total fat (g)	2.16 (1.60, 2.73)	<0.001	0.17 (-0.80, 1.15)	0.73
BMI kg/m²	2.59 (1.99, 3.19)	<0.001	1.00 (0.07, 1.93)	0.04
Bodyfat (skinfolds)	2.25 (1.70, 2.81)	<0.001	0.39 (-0.58, 1.37)	0.39
DXA L1L4 fat (g)	2.40 (1.83, 2.97)	<0.001	0.38 (-0.59, 1.35)	0.44
WHR	1.30 (0.70, 1.91)	<0.001	-0.31 (-1.47, 0.85)	0.60
Waist circumference	2.72 (2.12, 3.32)	<0.001	0.70 (-0.30, 1.69)	0.17

Values Are Relative Increases in Biomarkers Per 1 Standard Deviation in Adiposity Measure.
DXA measures additionally adjusted for DXA machine, DXA total fat (grams) and DXA L1L4 fat (grams) additionally adjusted for height. Sex specific Z-scores were created for these analyses.

ISSN: 1471-2458